specimen
clinic
confirm
sar
patient
fulfil
case
definit
admit
three
region
hospit
hong
kong
februari
april
studi
nasopharyng
aspir
npa
stool
specimen
collect
describ
previous
use
previous
publish
serolog
test
confirm
patient
seroposit
sar
cov
npa
stool
sampl
patient
unrel
diseas
recruit
control
rna
clinic
sampl
extract
use
qiaamp
viru
rna
mini
reagent
set
qiagen
instruct
manufactur
extract
rna
elut
rnasefre
water
store
complementari
dna
gener
describ
previous
briefli
elut
rna
sampl
reversetranscrib
u
superscript
ii
revers
transcriptas
invitrogen
reaction
contain
random
hexam
mm
dithiothreitol
mm
deoxynucleotid
triphosph
reaction
incub
min
follow
heat
inactiv
step
min
reversetranscrib
product
store
convent
pcr
perform
describ
previous
use
publish
sequenc
genbank
access
develop
quantit
rtpcr
assay
specif
open
read
frame
orf
region
n
gene
sar
cov
quantifi
amount
viral
cdna
sequenc
sampl
start
materi
cdna
origin
sampl
amplifi
taqman
pcr
core
reagent
sequenc
detect
system
appli
biosystem
briefli
cdna
amplifi
reaction
contain
u
amplitaq
gold
polymeras
appli
biosystem
taqman
buffer
mm
deoxynucleotid
triphosph
mm
u
amperas
ung
mixtur
assay
design
appli
biosystem
orf
gene
detect
primer
sequenc
correspond
nucleotid
sar
cov
genom
complementari
nucleotid
probe
fam
tctgcgtaggcaatcc
nfq
fam
nfq
nonfluoresc
quencher
complementari
nucleotid
n
gene
detect
primer
sequenc
correspond
nucleotid
complementari
nucleotid
probe
fam
accccaaggtttaccc
nfq
correspond
nucleotid
reaction
first
incub
min
follow
min
reaction
thermalcycl
cycl
min
serial
dilut
plasmid
contain
target
sequenc
use
calibr
run
confluent
vero
cell
infect
sar
cov
multipl
infect
infect
cell
incub
h
total
rna
cell
extract
use
trizol
reagent
invitrogen
instruct
manufactur
harvest
pure
genom
rna
virus
purifi
sucros
cushion
standard
laboratori
procedur
student
ttest
use
comparison
threshold
cycl
valu
differ
type
sampl
mcnemar
test
use
compar
detect
rate
sar
cov
differ
rtpcr
assay
clinic
specimen
collect
within
first
day
diseas
onset
studi
rna
extract
npa
n
stool
n
sampl
serolog
confirm
sar
patient
primer
pair
specif
orf
region
sar
cov
use
sar
cov
detect
posit
signal
observ
npa
stool
sampl
determin
rate
detect
sar
cov
differ
stage
diseas
data
npa
stool
sampl
analyz
subdivid
sampl
differ
day
diseas
onset
indic
tabl
npa
sampl
earli
onset
day
posit
detect
rate
increas
diseas
progress
day
npa
sampl
posit
assay
tabl
similarli
detect
rate
sar
cov
stool
sampl
increas
diseas
progress
day
two
eight
stool
sampl
posit
assay
tabl
contrast
stool
sampl
collect
day
diseas
onset
posit
tabl
rel
low
detect
rate
earli
diseas
prompt
us
establish
sensit
realtim
quantit
rtpcr
sar
cov
detect
first
target
orf
region
sar
cov
genom
rna
shown
fig
assay
dynam
rang
least
copi
per
reaction
water
control
neg
assay
evalu
specif
assay
npa
sampl
healthi
individu
patient
adenoviru
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
influenza
viru
n
infect
test
assay
posit
signal
observ
among
control
sampl
limit
avail
clinic
sampl
could
afford
test
avail
npa
n
stool
sampl
n
total
npa
stool
sampl
previous
test
convent
rtpcr
assay
randomli
select
quantit
rtpcr
analysi
day
quantit
rtpcr
assay
abl
detect
sar
cov
onehalf
npa
sampl
twothird
stool
sampl
tabl
contrast
approxim
onethird
sampl
posit
convent
assay
tabl
day
day
detect
rate
quantit
assay
becam
compar
convent
rtpcr
assay
result
indic
realtim
quantit
assay
better
diagnost
method
earli
sar
diagnosi
use
quantit
assay
also
determin
amount
orf
cdna
specimen
serial
dilut
plasmid
dna
contain
target
region
use
gener
calibr
curv
estim
copi
number
target
gene
cdna
sampl
shown
fig
progress
sar
within
first
day
reflect
increas
viral
load
npa
stool
sampl
infect
cell
coronavirus
known
gener
subgenom
mrna
synthesi
structur
viral
protein
discontinu
transcript
genom
organ
sar
cov
polycistron
viral
mrna
molecul
contain
sar
n
gene
thu
target
n
gene
sequenc
might
gener
sensit
assay
sar
diagnosi
address
question
develop
quantit
rtpcr
assay
specif
n
gene
sar
cov
fig
assay
dynam
rang
least
copi
per
reaction
signal
observ
water
control
posit
signal
observ
sampl
contain
cdna
healthi
individu
n
patient
adenoviru
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
influenza
viru
n
infect
sixtyeight
npa
sampl
test
realtim
assay
orf
region
randomli
select
test
n
gene
realtim
pcr
assay
interestingli
detect
rate
two
assay
similar
detect
rate
assay
compar
tabl
observ
statist
signific
differ
mcnemar
test
p
confirm
find
compar
ct
valu
orf
assay
ct
valu
n
gene
assay
ctn
sampl
posit
assay
use
analysi
first
determin
differ
ctn
sampl
ie
ctn
n
gene
assay
sensit
orf
assay
one
would
expect
sampl
would
much
greater
first
test
hypothesi
use
rna
isol
infect
cell
inde
even
virusinfect
cell
harvest
late
phase
viral
replic
h
postinfect
infect
cell
statist
greater
tabl
p
contrast
valu
npa
sampl
statist
differ
p
addit
also
determin
valu
stool
sampl
stool
sampl
statist
differ
tabl
p
thu
orf
n
gene
quantit
assay
equal
sensit
sar
cov
detect
clinic
specimen
data
analysi
tabl
overal
result
indic
amount
n
gene
sequenc
sampl
similar
result
highli
suggest
genom
rna
predomin
viral
rna
speci
clinic
sampl
test
hypothesi
serial
dilut
cdna
sampl
deriv
purifi
genom
rna
sampl
subject
orf
n
gene
quantit
assay
ct
valu
obtain
assay
use
deduc
linear
regress
line
shown
fig
ct
valu
npa
stool
sampl
correl
regress
line
deduc
genom
rna
addit
genom
rna
statist
differ
npa
p
stool
p
result
clearli
suggest
genom
rna
predomin
viral
rna
speci
clinic
sampl
detect
sar
cov
earli
cours
diseas
import
sever
reason
first
rapid
identif
sar
cov
allow
prompt
patient
manag
quarantin
therebi
minim
risk
larg
outbreak
hospit
local
commun
addit
earli
detect
viru
might
allow
earli
intervent
control
replic
pathogen
view
potenti
use
proteinas
inhibitor
inhibit
viral
replic
appli
quantit
rtpcr
technolog
sar
diagnosi
might
provid
valuabl
inform
prompt
clinic
treatment
result
demonstr
potenti
use
npa
stool
sampl
earli
sar
diagnosi
day
diseas
onset
approxim
onefourth
npa
stool
sampl
sar
patient
posit
convent
rtpcr
assay
detect
rate
sampl
increas
diseas
progress
sar
respiratori
diseas
low
detect
rate
sar
cov
stool
sampl
earli
diseas
onset
surpris
howev
strike
detect
rate
sar
cov
npa
sampl
isol
first
day
diseas
onset
surprisingli
low
possibl
explan
may
replic
site
sar
cov
earli
stage
diseas
restrict
lower
respiratori
tract
current
sar
patient
present
earli
cours
diseas
routin
use
multipl
stool
npa
sampl
collect
differ
time
point
increas
chanc
detect
sar
cov
low
detect
rate
sar
cov
earli
stage
diseas
prompt
us
develop
sensit
detect
assay
studi
focus
primarili
improv
detect
sar
cov
cdna
could
achiev
use
radioact
label
probe
detect
pcr
amplicon
howev
approach
often
requir
downstream
process
less
practic
routin
clinic
set
therefor
establish
realtim
quantit
rtpcr
assay
target
orf
region
sar
cov
result
demonstr
earli
cours
diseas
realtim
assay
orf
gene
sensit
convent
rtpcr
assay
tabl
howev
detect
rate
convent
realtim
assay
becam
similar
diseas
progress
observ
could
explain
fact
viral
rna
specimen
collect
later
time
point
fig
thu
sampl
collect
second
week
diseas
onset
amount
viral
rna
might
well
detect
limit
assay
previous
develop
sybr
green
detect
assay
sar
diagnosi
unlik
sybr
green
assay
current
assay
could
reveal
possibl
sequenc
variat
within
target
sequenc
howev
use
addit
probe
assay
minim
falseposit
result
importantli
work
platform
use
studi
could
increas
throughput
reaction
per
run
sever
convent
realtim
rtpcr
assay
develop
sar
cov
assay
howev
mainli
target
orf
region
sar
cov
sever
line
evid
suggest
detect
rate
sar
cov
might
increas
target
subgenom
mrna
sar
cov
howev
result
indic
least
npa
stool
sampl
particular
advantag
target
n
gene
clinic
diagnosi
contrari
one
consid
fact
polymeras
gene
rna
virus
genet
stabl
viral
gene
orf
region
sar
cov
might
better
candid
sar
diagnosi
isol
viabl
sar
cov
clinic
sampl
demonstr
presenc
viral
particl
clinic
sampl
indic
genom
rna
exist
specimen
result
show
genom
rna
might
predomin
viral
rna
speci
clinic
sampl
possibl
subgenom
mrna
might
present
clinic
sampl
unprotect
rapidli
degrad
endogen
rnase
contrast
encapsul
genom
viral
rna
protect
viral
particl
degrad
summari
determin
detect
rate
sar
cov
npa
stool
sampl
sar
patient
also
develop
two
realtim
quantit
assay
orf
n
gene
sequenc
pathogen
result
show
realtim
assay
sar
cov
particularli
use
earli
sar
diagnosi
result
studi
also
indic
sar
cov
rna
molecul
npa
stool
sampl
might
genom
rna
origin
result
take
us
closer
goal
prompt
identif
sar
cov
clinic
specimen
earli
diseas
therebi
lead
better
control
clinic
manag
diseas
